Home Healthcare Biotechnology Respiratory Disease Testing Market

Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product Type (Imaging Tests, Respiratory Measurement Devices, Blood Gas Tests, Others), By Application (Chronic Obstructive Pulmonary Diseases, Lung Cancer, Asthma, Tuberculosis, Others), By End Use (Hospitals, Physicians’ Clinics, Clinical Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 05, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Respiratory Disease Testing Market, By Product Type 2022–2034 (USD MILLION/ Units)
    1. Imaging Tests
    2. Respiratory Measurement Devices
    3. Blood Gas Tests
    4. Others
  2. Respiratory Disease Testing Market, By Application 2022–2034 (USD MILLION/ Units)
    1. Chronic Obstructive Pulmonary Diseases
    2. Lung Cancer
    3. Asthma
    4. Tuberculosis
    5. Others
  3. Respiratory Disease Testing Market, By End Use 2022–2034 (USD MILLION/ Units)
    1. Hospitals
    2. Physicians’ Clinics
    3. Clinical Laboratories
    4. Others
  4. Regional Respiratory Disease Testing Market
    1. North America
      1. North America Respiratory Disease Testing Market By Product Type 2022–2034 (USD MILLION/ Units)
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
      2. North America Respiratory Disease Testing Market By Application 2022–2034 (USD MILLION/ Units)
        1. Chronic Obstructive Pulmonary Diseases
        2. Lung Cancer
        3. Asthma
        4. Tuberculosis
        5. Others
      3. North America Respiratory Disease Testing Market By End Use 2022–2034 (USD MILLION/ Units)
        1. Hospitals
        2. Physicians’ Clinics
        3. Clinical Laboratories
        4. Others
      4. U.S.
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      5. Canada
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
    2. Europe
      1. Europe Respiratory Disease Testing Market By Product Type 2022–2034 (USD MILLION/ Units)
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
      2. Europe Respiratory Disease Testing Market By Application 2022–2034 (USD MILLION/ Units)
        1. Chronic Obstructive Pulmonary Diseases
        2. Lung Cancer
        3. Asthma
        4. Tuberculosis
        5. Others
      3. Europe Respiratory Disease Testing Market By End Use 2022–2034 (USD MILLION/ Units)
        1. Hospitals
        2. Physicians’ Clinics
        3. Clinical Laboratories
        4. Others
      4. U.K.
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      5. Germany
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      6. France
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      7. Spain
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      8. Italy
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      9. Russia
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      10. Nordic
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      11. Benelux
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      12. Rest of Europe
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
    3. APAC
      1. APAC Respiratory Disease Testing Market By Product Type 2022–2034 (USD MILLION/ Units)
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
      2. APAC Respiratory Disease Testing Market By Application 2022–2034 (USD MILLION/ Units)
        1. Chronic Obstructive Pulmonary Diseases
        2. Lung Cancer
        3. Asthma
        4. Tuberculosis
        5. Others
      3. APAC Respiratory Disease Testing Market By End Use 2022–2034 (USD MILLION/ Units)
        1. Hospitals
        2. Physicians’ Clinics
        3. Clinical Laboratories
        4. Others
      4. China
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      5. Korea
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      6. Japan
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      7. India
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      8. Australia
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      9. Taiwan
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      10. South East Asia
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      11. Rest of Asia-Pacific
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
    4. Middle East and Africa
      1. Middle East and Africa Respiratory Disease Testing Market By Product Type 2022–2034 (USD MILLION/ Units)
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
      2. Middle East and Africa Respiratory Disease Testing Market By Application 2022–2034 (USD MILLION/ Units)
        1. Chronic Obstructive Pulmonary Diseases
        2. Lung Cancer
        3. Asthma
        4. Tuberculosis
        5. Others
      3. Middle East and Africa Respiratory Disease Testing Market By End Use 2022–2034 (USD MILLION/ Units)
        1. Hospitals
        2. Physicians’ Clinics
        3. Clinical Laboratories
        4. Others
      4. UAE
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      5. Turkey
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      6. Saudi Arabia
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      7. South Africa
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      8. Egypt
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      9. Nigeria
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      10. Rest of MEA
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
    5. LATAM
      1. LATAM Respiratory Disease Testing Market By Product Type 2022–2034 (USD MILLION/ Units)
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
      2. LATAM Respiratory Disease Testing Market By Application 2022–2034 (USD MILLION/ Units)
        1. Chronic Obstructive Pulmonary Diseases
        2. Lung Cancer
        3. Asthma
        4. Tuberculosis
        5. Others
      3. LATAM Respiratory Disease Testing Market By End Use 2022–2034 (USD MILLION/ Units)
        1. Hospitals
        2. Physicians’ Clinics
        3. Clinical Laboratories
        4. Others
      4. Brazil
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      5. Mexico
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      6. Argentina
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      7. Chile
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      8. Colombia
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
      9. Rest of LATAM
        1. Imaging Tests
        2. Respiratory Measurement Devices
        3. Blood Gas Tests
        4. Others
        5. Chronic Obstructive Pulmonary Diseases
        6. Lung Cancer
        7. Asthma
        8. Tuberculosis
        9. Others
        10. Hospitals
        11. Physicians’ Clinics
        12. Clinical Laboratories
        13. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.